P. Hsyu

632 total citations
15 papers, 479 citations indexed

About

P. Hsyu is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, P. Hsyu has authored 15 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in P. Hsyu's work include HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). P. Hsyu is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). P. Hsyu collaborates with scholars based in United States, South Korea and United Kingdom. P. Hsyu's co-authors include KM Giacomini, Kathleen M. Giacomini, Kathy Chi‐Burris, Jack M. Gwaltney, Frederick G. Hayden, Ronald B. Turner, Merril Gersten, Amy K. Patick, L S Zalman and George J. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

P. Hsyu

15 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Hsyu United States	8	160	110	110	88	80	15	479
Andrew P. Lea Portugal	10	164 1.0×	74 0.7×	133 1.2×	127 1.4×	26 0.3×	11	676
Irma H. Benedek United States	10	132 0.8×	85 0.8×	44 0.4×	40 0.5×	88 1.1×	20	509
S. Hariharan United States	14	70 0.4×	98 0.9×	87 0.8×	108 1.2×	127 1.6×	37	679
Scott D. Studenberg United States	12	241 1.5×	186 1.7×	68 0.6×	95 1.1×	153 1.9×	14	530
F A deLuna United States	15	218 1.4×	292 2.7×	108 1.0×	164 1.9×	85 1.1×	24	844
Therese M Chapman United Kingdom	14	111 0.7×	51 0.5×	135 1.2×	195 2.2×	26 0.3×	17	830
Albert Dorr United States	15	194 1.2×	84 0.8×	348 3.2×	130 1.5×	65 0.8×	27	783
Araz Raoof Belgium	11	230 1.4×	77 0.7×	85 0.8×	142 1.6×	63 0.8×	22	608
Chan‐Loi Yong United States	13	260 1.6×	88 0.8×	400 3.6×	162 1.8×	28 0.3×	22	944
Neil Buss Switzerland	13	375 2.3×	61 0.6×	130 1.2×	98 1.1×	90 1.1×	17	655

Countries citing papers authored by P. Hsyu

Since Specialization

Citations

This map shows the geographic impact of P. Hsyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hsyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hsyu more than expected).

Fields of papers citing papers by P. Hsyu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hsyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hsyu. The network helps show where P. Hsyu may publish in the future.

Co-authorship network of co-authors of P. Hsyu

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hsyu. A scholar is included among the top collaborators of P. Hsyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hsyu. P. Hsyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kang, Dongwoo, et al.. (2009). Population pharmacokinetics (PK) of tremelimumab in patients (pts) with melanoma. Journal of Clinical Oncology. 27(15_suppl). 3048–3048. 5 indexed citations

Gordon, Michael, Mark N. Stein, Simantini Eddy, et al.. (2009). Phase I dose escalation trial of tremelimumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 27(15_suppl). 5115–5115. 6 indexed citations

Kang, Dongwoo, et al.. (2009). Relationship between pharmacokinetics and safety of tremelimumab in patients with melanoma. Journal of Clinical Oncology. 27(15_suppl). 3049–3049. 3 indexed citations

Benator, Debra, Marc Weiner, William J. Burman, et al.. (2007). Clinical Evaluation of the Nelfinavir‐Rifabutin Interaction in Patients with Tuberculosis and Human Immunodeficiency Virus Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(6). 793–800. 10 indexed citations

Lai, Ching‐Lung, Kwang‐Hyub Han, Sunkyung Yoon, et al.. (2006). 6 Phase II, multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV. Journal of Hepatology. 44. S5–S5. 5 indexed citations

Ford, Jennifer Lynn, David Cornforth, Patrick G. Hoggard, et al.. (2004). Intracellular and Plasma Pharmacokinetics of Nelfinavir and M8 in HIV-Infected Patients: Relationship with P-Glycoprotein Expression. Antiviral Therapy. 9(1). 77–84. 36 indexed citations

Hayden, Frederick G., Ronald B. Turner, Jack M. Gwaltney, et al.. (2003). Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 47(12). 3907–3916. 159 indexed citations

Heald, Alison E., P. Hsyu, Geoffrey J. Yuen, et al.. (1996). Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction. Antimicrobial Agents and Chemotherapy. 40(6). 1514–1519. 78 indexed citations

Hsyu, P., et al.. (1994). Validation of a liquid chromatography post-column derivatization assay for the determination of cisplatin in plasma. Journal of Pharmaceutical and Biomedical Analysis. 12(2). 265–271. 19 indexed citations

10.

Hsyu, P., L. G. Gisclon, Andrew Hui, & KM Giacomini. (1988). Interactions of organic anions with the organic cation transporter in renal BBMV. American Journal of Physiology-Renal Physiology. 254(1). F56–F61. 39 indexed citations

11.

Hsyu, P., et al.. (1988). The effect of pindolol on the transport of L-lysine in renal brush border membrane vesicles.. Drug Metabolism and Disposition. 16(3). 503–505. 1 indexed citations

12.

Hsyu, P. & Kathleen M. Giacomini. (1987). The pH gradient-dependent transport of organic cations in the renal brush border membrane. Studies with acridine orange.. Journal of Biological Chemistry. 262(9). 3964–3968. 39 indexed citations

13.

Hsyu, P. & KM Giacomini. (1987). Essential tyrosine residues in transport of organic cations in renal BBMV. American Journal of Physiology-Renal Physiology. 252(6). F1065–F1072. 7 indexed citations

14.

Hsyu, P. & KM Giacomini. (1985). Stereoselective renal clearance of pindolol in humans.. Journal of Clinical Investigation. 76(5). 1720–1726. 65 indexed citations

15.

Hsyu, P., et al.. (1984). Studies of the Interaction of Betacyclodextrin with Ampicillin, Methicillin and Phenytoin. Drug Development and Industrial Pharmacy. 10(4). 601–611. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact